While the expression and subcellular localisation of tetraspanin EV markers CD9 and CD63 are distinct in prostate cancer (Soekmadji et al., 2016), the effect of androgens such as DHT and ENZ on the S‐EVs profile is unclear. This evidence concerns the gene CD9 and prostate cancer.